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Abstract The e¡ect of sodium ion on the inhibition exerted by
Cbz-Leu-Leu-Leu-CHO on the chymotrypsin-like activity of the
20S proteasome isolated from bovine lung was investigated. The
experimental data were analyzed using a standard linkage for-
malism. The calculated equilibrium a⁄nity constants for the
sodium ion binding to the free-enzyme and the inhibitor-bound
enzyme are compatible to other well-characterized ion-involving
heterotropic systems. The functional interdependence between
the binding events played by the inhibitor and the sodium ion
conforms to a heterotropic modulatory mechanism.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The 20S proteasome or multicatalytic proteinase complex
(MPC) is a widespread, unusually high molecular weight pro-
teinase which is responsible for the non-lysosomal proteolytic
processing in all eukaryotic cells [1^4]. The functional mole-
cule is constituted by 14 non-identical subunits (M.W. 21^34
kDa), each present twice, exhibiting at least ¢ve distinct pro-
teolytic activities [5]. Several studies show that the catalytic
activities are associated to separate subunits of the complex
even though some of them derive from the cooperation of two
or more subunits and the structural integrity of the complex is
necessary for the expression of the proteolytic activity [6]. The
complex binds cooperatively some of its ligands, as appears
either from the substrate saturation kinetics exhibited by the
peptidyl^glutamyl peptide hydrolyzing (PGPH) activity or
from the dependence of one enzymatic activity by the modu-
lation exerted on the other proteolytic activities assembled on
the complex [7,8].
Several molecules are able to a¡ect both the catalytic prop-
erties of the complex or the mechanisms involved in the rec-
ognition of the substrate through the binding to speci¢c sites
on the catalytic subunits.
In particular it has been reported that, for the MPC pro-
teolytic activity, these e¡ects are played by several mono- or
divalent ions such as Naþ, Kþ, Mg2þ and Mn2þ.
It seems that some of these ions act as speci¢c heterotropic
e¡ectors contemporaneously a¡ecting, but with an opposite
e¡ect, the proteolytic activities assembled on the complex,
suggesting a composite mechanism of communication among
the subunits apparently mediated by the ions [8^11]. Djabal-
lah and coworkers [12], through sedimentation velocity experi-
ments, have shown that the e¡ects of several compounds on
the catalytic activities of the MPC complex is associated to
conformational changes a¡ecting the molecular shape. The
ligand-mediated conformational changes of the proteasome
experimentally con¢rm the allosteric nature of the modulation
exerted by divalent metal ions on MPC.
Some ions have an e¡ect only on some catalytic compo-
nents, as in the case of Mg2þ, inducing higher PGPH activity,
reducing the trypsin-like (T-L) activity and with no e¡ect on
the chymotrypsin-like (ChT-L) activity [10,13].
The ion Mn2þ seems to play a role in the modulation of the
catalytic properties of MPC from rat liver, especially in the
homotropic cooperativity exerted by the MPC toward the
substrate carbobenzoxy (Cbz)-LLE-L-naphtylamide (LNA)
[13].
Other compounds, such as fatty acids, heparin, RNA, ATP,
polylysine, spermidine [14], are known to act as e¡ectors of
the catalytic properties of MPC.
In order to better understand the e¡ect exerted by physio-
logically signi¢cant e¡ectors on the MPC activity, here we
report the results of a study performed on the MPC puri¢ed
from bovine lung, focusing our attention on the interplay
between the binding of a reversible inhibitor of the MPC,
the peptidyl aldehyde Cbz-Leu-Leu-Leu-CHO, and the bind-
ing of sodium ion. This three-partners interaction can be seen
as a model of the combined heterotropic modulation of e¡ec-
tors in solution on the 20S proteasome catalytic properties.
2. Materials and methods
2.1. Materials
Bovine lung was obtained from the local slaughter-house. The in-
hibitor Cbz-Leu-Leu-Leu-CHO (Mg132) and the synthetic substrate
Cbz-Gly-Gly-Leu-p-nitroanilide (pNa) were obtained from Sigma-Al-
drich. (USA).
All other chemicals were of analytical grade.
2.2. Enzyme puri¢cation
MPC was isolated from bovine lung using a puri¢cation strategy as
previously described [15] and essentially based on a fractionation from
40 to 60% in ammonium sulfate, an ionic exchange chromatography
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and two gel ¢ltration columns which favor the removal of lower
molecular weight contaminants. A higher degree of puri¢cation was
obtained adding a hydrophobic interaction chromatography step,
which seems to improve the separation of MPC from the co-purifying
chaperonin Hsp90. In detail, the ¢rst chromatographic step was a
DEAE^Sephacel column (5 cmU20 cm) in 0.01 M Tris^EDTA, pH
7.4; elution was carried out with a linear gradient established between
1 l of 0.01 M Tris^EDTA, pH 7.4, and 1 l of 0.5 M Tris^EDTA bu¡er
at the same pH, with a £ow rate of 2.75 ml/min. Fractions of 10 ml
were collected, assayed for the ChT-L activity and the active ones
(from 1580 to 1770 ml) were pooled, concentrated by ultra¢ltration
using YM10 membranes (Amicon) and loaded onto a Sephacryl S-300
(HiPrep 16/60, Pharmacia) in Tris^EDTA 200 mM, pH 8.3, with a
£ow rate of 0.5 ml/min. Active fractions (from 47 to 52 min) were
collected, concentrated and rechromatographed on a Superose 6 (10/
30, Pharmacia) equilibrated with 150 mM Tris^EDTA, pH 7.5, with a
£ow rate of 0.5 ml/min (the active fractions came out from 13 to 14
min). The last step of the puri¢cation was a hydrophobic interaction
chromatography on a TSK Phenyl-5PW column (8U75 mm, LKB),
equilibrated in Tris^EDTA 50 mM containing 2 M (NH4)2SO4, pH
7.5, and eluted with a linear gradient, in 60 min, between the equilib-
rium bu¡er and 50 mM Tris^EDTA, pH 7.5, using a £ow rate of 0.5
ml/min. Active fractions (from 3 to 4 min) were concentrated and the
bu¡er was exchanged with 0.01 M Tris^EDTA, pH 7.4.
The active fractions from the last puri¢cation step were pooled and
the resulting enzyme was homogeneous to a native PAGE (4.6%)
prepared using the standard method of Ornstein and Davis [16,17].
2.3. Determination of enzyme activity
The activity of MPC was determined measuring the ChT-L activity
of the complex. The assay mixture contained 40 Wl of a 10 mM solu-
tion in dimethyl sulfoxide of the chromogenic substrate Cbz-Gly-Gly-
Leu-pNa (0.4 mM, ¢nal concentration), a variable volume of the
enzyme solution, dialyzed in the assay bu¡er and containing about
40 Wg of protein, and 50 mM Tris^HCl, pH 8 (reaction bu¡er) up to a
¢nal volume of 1 ml. All the added salts were dissolved in the reaction
bu¡er up to the desired concentration. The complications arising from
non-speci¢c ionic strength e¡ects were eliminated using an inert chlo-
ride salt at constant ionic strength. All experiments were conducted at
a constant ionic strength of 32 mM by diluting the bu¡er containing
NaCl with choline chloride [18]. The reaction was started by the
addition of the substrate, following at 405 nm and 37‡C the formation
of the hydrolysis product for at least 20 min.
When the e¡ect of the inhibitors was assayed the dialyzed enzyme
was previously incubated for 10 min with the inhibitor.
One enzymatic unit is de¢ned as the amount of enzyme that pro-
duces 1 Wmol of product per hour.
2.4. Protein content
Protein content was determined according to Bradford [19] using
bovine serum albumin as standard.
3. Results
3.1. E¡ect of sodium ion on the binding of the reversible
inhibitor Cbz-LLL-CHO
The modulation of the binding of the Cbz-LLL-CHO by
Naþ can be seen as a general linkage scheme [20], where the
enzyme presents binding sites either for the ligand L (in our
case the inhibitor Cbz-LLL-CHO) or for the ion I, as shown
in Fig. 1, where the parameters L1 and L2 are the equilibrium
association constants for the enzyme^inhibitor complex in the
absence and presence of the modulating ion, respectively. The
other two parameters refer to the enzyme^ion complex equi-
librium association constants in the absence (V1) and presence
(V2) of the reversible inhibitor.
If the two phenomena (the binding of the reversible inhib-
itor and the release/uptake of the modulating ion) are linked,
the equilibrium association constant between the enzyme and
the inhibitor, measured at di¡erent ion concentrations Lapp,
will depend on the ion concentration. The apparent associa-
tion constant Lapp will change its value from L1 (no ion
present) to L2 (saturating ion concentration).
If the ion negatively modulates the enzyme^inhibitor com-
plex stability, then L1s L2, and, by symmetry, the condition
V1s V2 holds.
The modulating activity of the sodium ion toward the en-
zyme^inhibitor complex stability has been studied as shown in
Fig. 2.
The fraction of free enzyme or residual activity fraction
(13a) decreases upon the addition of increasing amounts of
reversible inhibitor Cbz-LLL-CHO. The inhibitory e¡ect is
reduced at increasing concentrations of sodium ion. The ex-
perimental data of the residual enzyme activity fraction (13a)
at increasing Cbz-LLL-CHO concentrations shown in Fig. 2
can be analyzed using a standard binding isotherm:
ð13a Þ ¼ 1
1þ L app½Cbz-LLL-CHO ð1Þ
where the apparent equilibrium association constant Lapp de-
pends on the ion concentration following a general linkage
relationship:
L app ¼ L 11þ V 2½Na
þ
1þ V 1½Naþ ð2Þ
At a given Naþ concentration, the free enzyme fraction
(13a) was measured at n increasing inhibitor concentrations
Fig. 1. General binding scheme for a coupled phenomenon such as
the binding of a reversible inhibitor and a release/uptake of a mod-
ulating ion.
Fig. 2. The residual enzyme activity (13a) of MPC inhibited by
Cbz-LLL-CHO at di¡erent ion concentrations: 1 WM (a), 31.6 WM
(+), 316 WM (x) 1.78 mM (*) and 31.6 mM (b) NaCl. For details
see Section 2.
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(at least n=7). The determinations were repeated at m in-
creasing Naþ concentrations (m=12). The resulting nU2Um
matrix constituted the experimental dataset, which was glob-
ally analyzed by the Marquardt^Levemberg non-linear least-
squares ¢tting procedure [21] using Eqs. 1 and 2 as ¢tting
functions.
Data analysis results are shown in Table 1, where the best-
¢tted values for the parameters together with the standard
deviations are reported.
Fig. 3 shows the apparent equilibrium constant as a func-
tion of the ion concentration. The negative modulation of the
ion is depicted as a decrease of the equilibrium association
constant for the enzyme^inhibitor complex.
The modulation of the EL complex stability is not the same
at all the L concentrations. We should refer to the
Q ¼ DX=D W y function (where Wy is, in this case, the Naþ
chemical potential) as de¢ned by Wyman and Gill [20] to
have a deeper understanding of the modulating interplay be-
tween the inhibitor L and the ion I as a function of their
concentrations.
Using the best-¢tted values obtained from the data shown
in Fig. 2, it can be noticed that at low concentrations of the
ion and the inhibitor, the heterotropic function Q does not
change much (see Fig. 4). The same situation is valid at
high concentrations.
The maximum value of the intermodulating heterotropic
function Q is reached at intermediate concentrations. The val-
ue of Q is always non-positive, con¢rming the negative mod-
ulation qualitatively shown in Figs. 2 and 3.
The modulating e¡ect exerted by sodium ion can be seen as
a signaling system, as illustrated by Wyman and Gill [20].
Upon the addition of one mole of inhibitor, the enzyme re-
leases (NaþL3Na
þ
U) moles of sodium ion, where Na
þ
U are the
moles of ion bound to the inhibitor-free enzyme, and NaþL are
the moles of ion bound to the inhibitor^enzyme complex. This
e¡ect depends on the sodium ion concentration following the
signaling equation:
ðNaþL3NaþUÞ ¼
V 2½Naþ
1þ V 2½Naþ3
V 1½Naþ
1þ V 1½Naþ ð3Þ
Fig. 5 shows the release of (NaþL3Na
þ
U) moles of sodium
ion upon the binding of one mole of inhibitor to the enzyme,
as described by Eq. 3.
4. Discussion
Several mono- or divalent ions such as Naþ, Kþ, Mg2þ and
Mn2þ a¡ect the MPC proteolytic activity [8^11].
Some of these ions act as speci¢c allosteric modulators con-
temporaneously a¡ecting, but with an opposite e¡ect, the as-
sembled proteolytic activities on the complex, suggesting a
Table 1
Parameter values obtained by global non-linear regression analysis
of the experimental data presented in Fig. 1 using Eqs. 1 and 2 as
¢tting functions
Parameter name Parameter value (M31) S S.D.
V1 3020S 150
V2 631S 92
L1 724S 60
The standard deviations for the parameters were obtained by a
standard Monte Carlo procedure [21].
Fig. 3. Apparent equilibrium constant as a function of the ion con-
centration. The calculated apparent equilibrium constants calculated
for each binding curve shown in Fig. 2 are reported vs. log NaCl
(M). The sigmoid curve is the theoretical curve obtained using Eq.
2 and the best-¢tted values for the V1 and V2 parameters reported
in Table 1.
Fig. 4. Heterotropic second derivative Q for the interaction of MPC
with Naþ and Cbz-LLL-CHO. The three-dimensional plot has been
obtained from the Q ¼ DX=D W y function, using the parameters re-
ported in Table 1.
Fig. 5. Release of sodium ion upon inhibitor binding to the protea-
some as a function of increasing sodium ion concentration as ob-
tained by Eq. 3, where the best-¢tted values for the V1 and V2 pa-
rameters reported in Table 1 were used.
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composite mechanism of communication among the subunits
apparently mediated by the ions.
The focus of the present work is the quantitative analysis of
the functional interplay between the binding of the peptide
Cbz-Leu-Leu-Leu-CHO, a reversible inhibitor of the MPC,
and the binding of sodium ions.
The analysis of the experimental data clearly indicates a
negative heterotropic e¡ect mutually exerted by the peptid-
yl^aldehyde inhibitor and the sodium ion. Considering the
di¡erent nature of the two ligands (a small ion and a mainly
hydrophobic small peptide), it is reasonable to suppose that
Naþ plays its role as modulatory e¡ector, as seen for other
proteases [18]. In addition, the inhibitor participates in the
heterotropic mechanism despite its size. This result is rela-
tively unexpected because similar e¡ects on proteolytic sys-
tems have been previously described only for the binding of
macromolecular inhibitors [22]. This e¡ect con¢rms the pro-
teasome’s peculiar conformational sensitivity in comparison
with other proteases [5].
The experimental data can be analyzed through a model
based on a 1:1 stoichiometry between the two ligands, even
if the linkage functional analysis used is able to handle only
overall events. In fact, structural studies would be necessary to
dissect the overall negative heterotropic process into distinct
events which could even be locally positive [23,24].
The equilibrium stability constants for the enzyme^sodium
complex and for the ternary enzyme^inhibitor^sodium com-
plex, namely V1 and V2, albeit not high, are comparable with
the a⁄nity values of ions for other proteins, such as chloride
binding to human hemoglobin [20,25] or aluminum binding to
chymotrypsin [22].
The negative heterotropic e¡ect can be seen as an intracel-
lular signaling system, at least in the thermodynamical frame-
work de¢ned by Wyman [20]. The maximum signaling e¡ect is
around the V1 value (3 mM) (as shown in Fig. 4), in the
physiological range of intracellular sodium concentration,
suggesting a physiological relevance for this mechanism. In
fact, while the Cbz inhibitor is small in size in comparison
to other e¡ectors in solution, it is noteworthy that the pro-
teasome recognition can be modulated even in the case of
small reversible inhibitors by sodium ion.
There is direct and indirect evidence that the 20S protea-
some exists in distinct functional conformations [8,26]. The
existence of at least two distinct but interconverting confor-
mations has been demonstrated for the 20S proteasome: the
macromolecular architecture can be switched by allosteric ef-
fectors, including small peptides and bivalent metal ions [26].
The addition of the reversible inhibitor Cbz-LLL-CHO re-
sulted mainly in a closed-barrel distribution, similar to those
obtained upon addition of weak ligands and irreversible in-
hibitors. The e¡ect of sodium ion as heterotropic ligand pre-
sented in this paper suggests that the simple two-state model
could be an approximation of the complex modulation mech-
anism of the 20S proteasome functionality.
In conclusion, while the interplay between sodium and the
reversible inhibitor Cbz-LLL-CHO binding to MPC is an ex-
cellent model for modulatory mechanisms in large macro-
molecules, the e¡ect of sodium ion is relevant. In fact Naþ
could play a signi¢cant role in the MPC modulation ‘in vivo’,
where its intracellular concentration is close to the one ob-
served having the maximum heterotropic e¡ect.
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